These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 26767511)
1. Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid. Kumar A; Bicer EM; Morgan AB; Pfeffer PE; Monopoli M; Dawson KA; Eriksson J; Edwards K; Lynham S; Arno M; Behndig AF; Blomberg A; Somers G; Hassall D; Dailey LA; Forbes B; Mudway IS Nanomedicine; 2016 May; 12(4):1033-1043. PubMed ID: 26767511 [TBL] [Abstract][Full Text] [Related]
2. Differences in the coronal proteome acquired by particles depositing in the lungs of asthmatic versus healthy humans. Kumar A; Bicer EM; Pfeffer P; Monopoli MP; Dawson KA; Eriksson J; Edwards K; Lynham S; Arno M; Behndig AF; Blomberg A; Somers G; Hassall D; Dailey LA; Forbes B; Mudway I Nanomedicine; 2017 Nov; 13(8):2517-2521. PubMed ID: 28647590 [TBL] [Abstract][Full Text] [Related]
3. Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q. Ding T; Sun J Pharm Res; 2019 Dec; 37(1):10. PubMed ID: 31872347 [TBL] [Abstract][Full Text] [Related]
4. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood. Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ ACS Nano; 2020 Nov; 14(11):15723-15737. PubMed ID: 33112593 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the human and mouse protein corona profiles of functionalized SiO Solorio-Rodríguez A; Escamilla-Rivera V; Uribe-Ramírez M; Chagolla A; Winkler R; García-Cuellar CM; De Vizcaya-Ruiz A Nanoscale; 2017 Sep; 9(36):13651-13660. PubMed ID: 28875999 [TBL] [Abstract][Full Text] [Related]
6. Link between Low-Fouling and Stealth: A Whole Blood Biomolecular Corona and Cellular Association Analysis on Nanoengineered Particles. Weiss ACG; Kelly HG; Faria M; Besford QA; Wheatley AK; Ang CS; Crampin EJ; Caruso F; Kent SJ ACS Nano; 2019 May; 13(5):4980-4991. PubMed ID: 30998312 [TBL] [Abstract][Full Text] [Related]
7. What are the biological and therapeutic implications of biomolecule corona formation on the surface of inhaled nanomedicines? Kumar A; Forbes B; Mudway I; Bicer EM; Dailey LA Nanomedicine (Lond); 2015 Feb; 10(3):343-5. PubMed ID: 25707971 [No Abstract] [Full Text] [Related]
8. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition. Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243 [TBL] [Abstract][Full Text] [Related]
9. Tuning complement activation and pathway through controlled molecular architecture of dextran chains in nanoparticle corona. Coty JB; Eleamen Oliveira E; Vauthier C Int J Pharm; 2017 Nov; 532(2):769-778. PubMed ID: 28450168 [TBL] [Abstract][Full Text] [Related]
11. Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona. Strojan K; Leonardi A; Bregar VB; Križaj I; Svete J; Pavlin M PLoS One; 2017; 12(1):e0169552. PubMed ID: 28052135 [TBL] [Abstract][Full Text] [Related]
12. Influence of nanoparticle mechanical property on protein corona formation. Tengjisi ; Hui Y; Fan Y; Zou D; Talbo GH; Yang G; Zhao CX J Colloid Interface Sci; 2022 Jan; 606(Pt 2):1737-1744. PubMed ID: 34507167 [TBL] [Abstract][Full Text] [Related]
13. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection. Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454 [TBL] [Abstract][Full Text] [Related]
15. Microfluidic Examination of the "Hard" Biomolecular Corona Formed on Engineered Particles in Different Biological Milieu. Weiss ACG; Kempe K; Förster S; Caruso F Biomacromolecules; 2018 Jul; 19(7):2580-2594. PubMed ID: 29668268 [TBL] [Abstract][Full Text] [Related]
16. Protein corona: implications for nanoparticle interactions with pulmonary cells. Konduru NV; Molina RM; Swami A; Damiani F; Pyrgiotakis G; Lin P; Andreozzi P; Donaghey TC; Demokritou P; Krol S; Kreyling W; Brain JD Part Fibre Toxicol; 2017 Oct; 14(1):42. PubMed ID: 29084556 [TBL] [Abstract][Full Text] [Related]
17. Stealth effect of biomolecular corona on nanoparticle uptake by immune cells. Caracciolo G; Palchetti S; Colapicchioni V; Digiacomo L; Pozzi D; Capriotti AL; La Barbera G; Laganà A Langmuir; 2015 Oct; 31(39):10764-73. PubMed ID: 26378619 [TBL] [Abstract][Full Text] [Related]
18. Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages. Shaw CA; Mortimer GM; Deng ZJ; Carter ES; Connell SP; Miller MR; Duffin R; Newby DE; Hadoke PW; Minchin RF Nanotoxicology; 2016 Sep; 10(7):981-91. PubMed ID: 27027807 [TBL] [Abstract][Full Text] [Related]
19. The biomolecule corona mediates pulmonary delivery of nanomedicine. Subramaniam S; Joyce P; Prestidge CA Eur J Pharm Biopharm; 2024 Sep; 202():114420. PubMed ID: 39038525 [TBL] [Abstract][Full Text] [Related]
20. Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure. Lara S; Perez-Potti A; Herda LM; Adumeau L; Dawson KA; Yan Y ACS Nano; 2018 May; 12(5):4930-4937. PubMed ID: 29668255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]